Global generic drug and specialty pharmaceuticals maker Mylan has turned to Skadden, Arps, Slate, Meagher & Flom, Magic Circle shop Slaughter and May, and Indian firm Platinum Partners for counsel on its $1.6 billion acquisition of Indian generic injectable drug manufacturer Agila Specialties from parent Strides Arcolab. Haynes and Boone, Herbert Smith Freehills, and firms from Brazil and India are advising the seller.
Seven Firms Advise on Mylan's $1.6 Billion Generic Drug Buy
The Am Law Daily
February 28, 2013
This article requires premium access
This article requires premium access to The American Lawyer. Please sign in or subscribe to read the full text.